Tailored Tobacco Quitline for Rural Veterans

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Cigarette Smoking
Interventions
DRUG

Nicotine replacement therapy - transdermal nicotine patch

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

BEHAVIORAL

Tailored behavioral intervention

Participants will receive a standard six session cognitive behavioral intervention for smoking cessation combined with supplemental treatment modules based on individual need and preference.

BEHAVIORAL

Tobacco quit line referral

Participants assigned to this condition will receive a referral to their state tobacco quit line. The specific behavioral treatment that is provided will differ slightly depending upon the services available through the participant's state of residence.

DRUG

Nicotine replacement therapy - nicotine gum

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Nicotine replacement therapy - nicotine lozenge

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Bupropion Sustained Release

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Varenicline

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Combination pharmacotherapy - transdermal nicotine patch + nicotine gum

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

DRUG

Combination pharmacotherapy - transdermal nicotine patch + bupropion

Medication selection will be determined based on individual participant preferences, medical history, and contraindications

BEHAVIORAL

Alcohol use risk reduction

Participants engaging in risky alcohol use may receive this six-session telephone-based behavioral intervention for reducing alcohol use.

BEHAVIORAL

Behavioral activation for the treatment of depression

Participants with elevated depressive symptoms may receive this six-session telephone-based behavioral activation intervention.

BEHAVIORAL

Behavioral management of post-cessation weight gain

Participants with concerns about gaining weight after quitting smoking may receive this six-session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.

Trial Locations (1)

52246

Iowa City VA Health Care System, Iowa City

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Iowa City Veterans Affairs Medical Center

FED

NCT01592695 - Tailored Tobacco Quitline for Rural Veterans | Biotech Hunter | Biotech Hunter